27 April 2025, Boston—In places like Australia, where metropolitan areas are separated by an entire continent, donor hearts used to go unused simply because transplant teams couldn’t get the organ to ...
LONDON--(BUSINESS WIRE)--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today announced it received U.S. Food and Drug Administration (FDA) 510(k) clearance ...
Professional expert questionnaire: https://forms.office.com/e/NrEbUj7mDp People and Communities Partners (patient expert) form: https://online1.snapsurveys.com ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. LivaNova announced it received FDA 510(k) clearance for ...
Read full article: Navigating HPV vaccine hesitancy: A doctor debunks myths, encourages cancer prevention Dr. Kyle Miletic, surgeon, talks about the procedure with heart transplant recipient Ken ...
Please provide your email address to receive an email when new articles are posted on . The use of normothermic regional perfusion could injure donor lungs meant for transplantation. More research is ...
The FDA clearance enables the commercial use of VitaSmart (TM) for hypothermic oxygenated perfusion of donor livers following static cold storage and prior to transplantation, providing a clear, ...
27 April 2025, Boston—A study on donor lungs preserved outside the body before transplantation demonstrated that the hypothermic oxygenated machine perfusion (HOPE) technique is a safe and effective ...
LONDON--(BUSINESS WIRE)--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced it received U.S. Food and Drug Administration (FDA) 510(k) clearance and CE Mark for ...
University of Virginia Medical Center has earned the Extracorporeal Life Support Organization’s Platinum Level Center of Excellence Award, the international group’s highest honor. Fewer than 30 ...
Dr. John Gibbon invented the heart-lung machine and used it to perform the world’s first successful open-heart surgery on May 6, 1953. Dr. John Gibbon was a researcher and surgeon at Jefferson Medical ...